Galenical formulations of Aliskiren

摘要

The present invention relates to a roller compacted solid oral dosage form comprising a therapeutically effective amount of Aliskiren, or a pharmaceutically acceptable salt thereof, wherein the active ingredient is present in an amount of more than 38% by weight based on the total weight of the oral dosage form, as well as a process of preparing said solid oral dosage form.